Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1994;3(6):415–418. doi: 10.1155/S096293519400058X

Analysis of Signals Leading to Differentiation of Immature HL-60 after Administration of IL-4

Simon Vassiliadis 1
PMCID: PMC2365590  PMID: 18475589

Abstract

Treatment of acute myeloid leukaemia (AML) cells with differentiation agents leads not only to the acquisition of normal phenotypes but also contributes to the understanding of special immuno-haematology issues. For instance, induction of HLA-DR antigens on human promyelocytic leukaemia HL-60 cells by interleukin-4 (IL-4) is of pivotal importance in immunology not only because class II expression is prerequisite to antigen recognition and response but also because IL-4 participates in a plethora of inflammatory or non-inflammatory reactions. At the same time, the same observation coupled with an increase in Mac-1, mature monocyte marker, is revealing ways to haematologists for converting malignant cases to normal situations. Based on previous reports that HLA-DR induction by IL-4 in the HL-60 system is mediated via the G-protein system (p21ras), this study was undertaken in order to define the intermediate signalling steps followed by this agent from the moment it is added to cultures to the differentiated cellular form obtained. It is proposed that IL-4 increases p21ras which in turn suppresses the HL-60 cells' p34cdc2 constitutive expression. This inhibition appears to be responsible for the subsequently.observed cessation ofgrowth. Concomitant to decreased cellular proliferation, HI-DR antigen expression increases, a finding that matches the initially mentioned induction of p21ras since its inhibition abolishes HI-DR upregulation.

Full Text

The Full Text of this article is available as a PDF (377.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adkins B., Mueller C., Okada C. Y., Reichert R. A., Weissman I. L., Spangrude G. J. Early events in T-cell maturation. Annu Rev Immunol. 1987;5:325–365. doi: 10.1146/annurev.iy.05.040187.001545. [DOI] [PubMed] [Google Scholar]
  2. Atherton-Fessler S., Parker L. L., Geahlen R. L., Piwnica-Worms H. Mechanisms of p34cdc2 regulation. Mol Cell Biol. 1993 Mar;13(3):1675–1685. doi: 10.1128/mcb.13.3.1675-1685.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Collins S. J., Gallo R. C., Gallagher R. E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature. 1977 Nov 24;270(5635):347–349. doi: 10.1038/270347a0. [DOI] [PubMed] [Google Scholar]
  4. Collins S. J. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood. 1987 Nov;70(5):1233–1244. [PubMed] [Google Scholar]
  5. Donnelly R. P., Crofford L. J., Freeman S. L., Buras J., Remmers E., Wilder R. L., Fenton M. J. Tissue-specific regulation of IL-6 production by IL-4. Differential effects of IL-4 on nuclear factor-kappa B activity in monocytes and fibroblasts. J Immunol. 1993 Nov 15;151(10):5603–5612. [PubMed] [Google Scholar]
  6. Fibach E., Peled T., Rachmilewitz E. A. Self-renewal and commitment to differentiation of human leukemic promyelocytic cells (HL-60). J Cell Physiol. 1982 Oct;113(1):152–158. doi: 10.1002/jcp.1041130124. [DOI] [PubMed] [Google Scholar]
  7. Meyerson M., Enders G. H., Wu C. L., Su L. K., Gorka C., Nelson C., Harlow E., Tsai L. H. A family of human cdc2-related protein kinases. EMBO J. 1992 Aug;11(8):2909–2917. doi: 10.1002/j.1460-2075.1992.tb05360.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Pan B. T., Chen C. T., Lin S. M. Oncogenic Ras blocks cell cycle progression and inhibits p34cdc2 kinase in activated Xenopus egg extracts. J Biol Chem. 1994 Feb 25;269(8):5968–5975. [PubMed] [Google Scholar]
  9. Paul W. E. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood. 1991 May 1;77(9):1859–1870. [PubMed] [Google Scholar]
  10. Streck R. J., Hurley E. L., Pauly J. L. Expression and capping of a proliferation-associated surface membrane p34 kDa antigen on different human hematopoietic cell lines. J Leukoc Biol. 1991 Aug;50(2):182–191. doi: 10.1002/jlb.50.2.182. [DOI] [PubMed] [Google Scholar]
  11. Vassiliadis S., Kyrpides N., Papamatheakis J. The role of IL-4 in human myeloid leukemia: stimulation of RNA synthesis and transduction of differentiation signals through an IL-4 receptor leads to functional and HLA positive HL-60 cells. Leuk Lymphoma. 1992 Jun;7(3):235–242. doi: 10.3109/10428199209053628. [DOI] [PubMed] [Google Scholar]
  12. Vassiliadis S., Kyrpides N., Stravopodis D., Grigoriou M., Athanassakis I., Papamatheakis J. Investigation of intracellular signals generated by gamma-interferon and IL-4 leading to the induction of class II antigen expression. Mediators Inflamm. 1993;2(5):343–348. doi: 10.1155/S096293519300047X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Vassiliadis S., Papamatheakis J. The p21ras protein as an intermediate signaling molecule in the IL-4-induced HLA-DR expression on normal and leukemic human myeloid cells. Cell Immunol. 1992 Jul;142(2):426–433. doi: 10.1016/0008-8749(92)90302-6. [DOI] [PubMed] [Google Scholar]
  14. von Boehmer H. The developmental biology of T lymphocytes. Annu Rev Immunol. 1988;6:309–326. doi: 10.1146/annurev.iy.06.040188.001521. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES